Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
3.960
-0.030 (-0.75%)
At close: Mar 27, 2026
HKG:2185 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 92.28 | 202.39 | 369.44 | 451.32 | 708.53 |
Short-Term Investments | 156.24 | - | - | - | - |
Cash & Short-Term Investments | 248.52 | 202.39 | 369.44 | 451.32 | 708.53 |
Cash Growth | 22.80% | -45.22% | -18.14% | -36.30% | 56.18% |
Accounts Receivable | 17.85 | - | - | - | - |
Other Receivables | 1.74 | - | 6.12 | 5.8 | 8.91 |
Receivables | 19.58 | - | 6.12 | 5.8 | 8.91 |
Inventory | 32.18 | 18.33 | 3.98 | - | - |
Other Current Assets | 81.62 | 78.31 | 28.93 | 84.41 | 39.08 |
Total Current Assets | 381.91 | 299.03 | 408.47 | 541.53 | 756.53 |
Property, Plant & Equipment | 62.47 | 51.58 | 30.91 | 75.98 | 72.26 |
Long-Term Investments | 67.99 | 53.91 | 87.06 | 73.23 | - |
Goodwill | 144.63 | 144.63 | 144.63 | 144.63 | 144.63 |
Other Intangible Assets | 126.03 | 137.59 | 137.71 | 137.54 | 137.2 |
Long-Term Deferred Tax Assets | 7.02 | - | - | - | - |
Other Long-Term Assets | 42.43 | 47.05 | 9.12 | 8.61 | 4.3 |
Total Assets | 832.48 | 733.78 | 817.9 | 981.52 | 1,115 |
Accounts Payable | 2.22 | 0.1 | - | - | 0.01 |
Accrued Expenses | - | 13.77 | 8.6 | 8.02 | 9.14 |
Current Portion of Leases | 2.25 | 1.27 | 1.58 | 7.62 | 7.31 |
Current Unearned Revenue | 0.67 | - | 3.39 | 0.96 | 0.98 |
Other Current Liabilities | 19.9 | 4.52 | 6.5 | 12.25 | 19.37 |
Total Current Liabilities | 25.03 | 19.65 | 20.07 | 28.85 | 36.81 |
Long-Term Leases | 10.48 | 7.01 | 0.18 | 10.49 | 15.14 |
Long-Term Unearned Revenue | 4.62 | 6 | 3.21 | 6.55 | 7.52 |
Long-Term Deferred Tax Liabilities | 0.03 | 20.58 | 20.58 | 20.58 | 20.58 |
Other Long-Term Liabilities | 180.21 | - | - | - | - |
Total Liabilities | 220.38 | 53.24 | 44.04 | 66.47 | 80.04 |
Common Stock | 243.42 | 243.94 | 243.94 | 243.94 | 243.94 |
Additional Paid-In Capital | - | 662.42 | 662.42 | 662.42 | 662.42 |
Retained Earnings | - | - | - | -673.44 | -469.21 |
Treasury Stock | - | -29.44 | -29.44 | -29.44 | - |
Comprehensive Income & Other | 191.4 | -216.45 | -128.51 | 679.74 | 558.54 |
Total Common Equity | 434.82 | 660.47 | 748.41 | 883.21 | 995.69 |
Minority Interest | 177.28 | 20.07 | 25.45 | 31.84 | 39.19 |
Shareholders' Equity | 612.1 | 680.53 | 773.86 | 915.05 | 1,035 |
Total Liabilities & Equity | 832.48 | 733.78 | 817.9 | 981.52 | 1,115 |
Total Debt | 12.73 | 8.28 | 1.76 | 18.11 | 22.45 |
Net Cash (Debt) | 235.8 | 194.1 | 367.68 | 433.21 | 686.09 |
Net Cash Growth | 21.48% | -47.21% | -15.13% | -36.86% | 51.67% |
Net Cash Per Share | 0.98 | 0.80 | 1.51 | 1.78 | 3.11 |
Filing Date Shares Outstanding | 239.71 | 243.42 | 243.42 | 243.42 | 243.94 |
Total Common Shares Outstanding | 239.71 | 243.42 | 243.42 | 243.42 | 243.94 |
Working Capital | 356.88 | 279.38 | 388.4 | 512.68 | 719.72 |
Book Value Per Share | 1.81 | 2.71 | 3.07 | 3.63 | 4.08 |
Tangible Book Value | 164.16 | 378.25 | 466.07 | 601.04 | 713.86 |
Tangible Book Value Per Share | 0.68 | 1.55 | 1.91 | 2.47 | 2.93 |
Buildings | - | 20.25 | - | - | - |
Machinery | - | 39.31 | 53.24 | 38.66 | 33.57 |
Construction In Progress | - | - | - | 8.16 | 19.63 |
Leasehold Improvements | - | 22.38 | 21.82 | 61.85 | 31.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.